Manning & Napier Group, LLC
- SEC CIK
- 0001725248
- Latest filing
- Apr 15, 2024
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Manning & Napier Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q1 2024 holdings
- Shares (Q1 2024)
- 271,786
- Value
- $3.77M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 271,786 | $3.77M | <0.1% | −26,100−8.8% | Reduced | Holders |
| Q4 2023 | 297,886 | $4.25M | 0.1% | −4,381−1.4% | Reduced | Holders |
| Q3 2023 | 302,267 | $4.68M | 0.1% | −3,189−1.0% | Reduced | Holders |
| Q2 2023 | 305,456 | $4.80M | 0.1% | +22,939+8.1% | Added | Holders |
| Q1 2023 | 282,517 | $4.66M | 0.1% | −7,646−2.6% | Reduced | Holders |
| Q4 2022 | 290,163 | $4.53M | 0.1% | −5,543−1.9% | Reduced | Holders |
| Q3 2022 | 295,706 | $3.83M | 0.1% | +907+0.3% | Added | Holders |
| Q2 2022 | 294,799 | $4.14M | <0.1% | +3,397+1.2% | Added | Holders |
| Q1 2022 | 291,402 | $4.17M | <0.1% | −27,903−8.7% | Reduced | Holders |
| Q4 2021 | 319,305 | $4.35M | <0.1% | −2,717−0.8% | Reduced | Holders |
| Q3 2021 | 322,022 | $5.27M | <0.1% | −2,207−0.7% | Reduced | Holders |
| Q2 2021 | 324,229 | $5.46M | <0.1% | +324,229 | New | Holders |